Matrix metalloproteinase-9 gene -1562C/T polymorphism mitigates preeclampsia

Area of Science:

• Reproductive biology
• Genetics
• Obstetrics

Background:

• Preeclampsia etiology is unknown, but abnormal placentation is implicated.
• Successful placentation requires trophoblast invasion, extracellular matrix remodeling, and apoptosis without thrombosis.

Purpose of the Study:

• To investigate the association between functional gene polymorphisms in MMP9, MMP3, and annexin A5 and preeclampsia risk.
• To analyze the effect of these polymorphisms on placentation processes.

Main Methods:

• Case-control study involving 163 women with preeclampsia and 163 controls.
• Analysis of MMP9 (-1562 C/T), MMP3 (-1612 5A/6A), and annexin A5 (-1 C/T) gene polymorphisms using logistic regression.

Main Results:

• A lower prevalence of the MMP9 (-1562 C/T) T allele was observed in women with preeclampsia (OR 0.48).
• No significant association was found for MMP3 and annexin A5 polymorphisms.
• The MMP9-1562T allele may be linked to reduced risk of preeclampsia.

Conclusions:

• The MMP9-1562T allele appears to be associated with a reduced risk of preeclampsia.
• This polymorphism may protect against spiral artery maladaptation and insufficient decidual degradation.
• Elevated MMP9 concentrations linked to the -1562T allele might be crucial for early maternal-fetal interface development.